Position in BMRN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$339,142
+$4,326 QoQ
Shares Held
5,927
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#371
of 561 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CIBC Asset Management Inc holds $114,884,709 across 45 Biotechnology names. BMRN ranks #18 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
104,292 | $51,804,965 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
41,660 | $25,976,676 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,342 | $8,832,822 | |
| 4 | INCY |
Incyte Corp
|
63,141 | $7,157,663 | |
| 5 | MRNA |
Moderna, Inc.
|
78,815 | $5,519,414 | |
| 6 | TECH |
BIO-TECHNE Corp
|
34,505 | $2,437,778 | |
| 7 | RPRX |
Royalty Pharma plc
|
34,087 | $1,911,258 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
8,768 | $1,642,071 |
All Filings in BMRN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $339,142 | 5,927 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $334,816 | 5,927 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $353,786 | 5,953 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $444,166 | 8,201 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $447,620 | 8,143 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $571,882 | 8,090 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $503,294 | 7,657 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $473,121 | 6,731 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $524,606 | 6,372 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $528,144 | 6,047 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $581,798 | 6,034 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $573,261 | 6,479 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $548,164 | 6,324 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $614,556 | 6,320 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $621,871 | 6,009 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $698,674 | 8,242 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $681,191 | 8,220 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $908,931 | 11,789 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $3,586,479 | 40,594 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $3,066,403 | 39,674 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,779,219 | 33,308 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,252,614 | 29,832 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $587,873 | 6,704 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,439,890 | 18,926 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $2,209,019 | 17,910 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $1,453,569 | 17,202 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||